In light of Eli Lilly's impressive financial performance, strategic expansion, and strong analyst endorsements, the company seems poised for continued growth. Even with its stock trading near all-time ...

A Maine resident is seeking class-action status for a suit accusing Elevance Health of discrimination because it declines to ...

In an investor update on Tuesday, Amgen Inc (NASDAQ:AMGN) released data from Phase 3 trials of rocatinlimab and Uplizna ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 598.51% and ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...